View of New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab

Return to Article Details New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab Download Download PDF